| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |